Search

Search Constraints

You searched for: Author/Creator Suh, James

Search Results

1. ALK Fusions in a Wide Variety of Tumor Types Respond to Anti‐ALK Targeted Therapy. (4th December 2017)

2. Characterization of 298 Patients with Lung Cancer HarboringMETExon 14 Skipping Alterations. Issue 9 (September 2016)

3. Comprehensive Genomic Profiling of 282 Pediatric Low‐ and High‐Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures. (4th December 2017)

4. Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy. Issue 18 (5th June 2017)

5. Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options. (11th May 2017)

6. Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options. (July 2017)

7. Evaluation of 122 advanced‐stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies. Issue 2 (19th October 2015)

8. Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes. (April 2019)

9. Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic Melanoma. (January 2017)

10. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti‐HER2 targeted therapies. Issue 17 (10th June 2016)